U.S. Artificial Corneal Implants Market Size, Share & Trends Analysis Report By Transplant Type (Hard Keratoprosthesis, Soft Keratoprosthesis), By Indication (Ocular Cicatricial Pemphigoid, Keratoconus), By Implant Type (Synthetic, Biosynthetic), By End-use, And Segment Forecasts, 2025 - 2033
U.S. Artificial Corneal Implants Market Summary
The U.S. artificial corneal implants market size was estimated at USD 39.1 million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.
The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.
To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.
U.S. Artificial Corneal Implants Market Report Segmentation
This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:
The U.S. artificial corneal implants market size was estimated at USD 39.1 million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.
The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.
To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.
U.S. Artificial Corneal Implants Market Report Segmentation
This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:
- Transplant Type Outlook (Revenue, USD Million, 2021 - 2033)
- Hard Keratprosthesis
- Boston Kpro
- Osteo-Odonto-Keratoprosthesis
- Soft Keratoprosthesis
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Stevens-Johnson Syndrome (SJS)
- Ocular Cicatricial Pemphigoid (OCP)
- Ocular burns
- Keratoconus
- Corneal Stromal Dystrophies
- Others
- Implant Type Outlook (Revenue, USD Million, 2021 - 2033)
- Synthetic
- Biosynthetic
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ophthalmic Centers
- Ambulatory Surgical Centers
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.4. Information Procurement
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Artificial Corneal Implants Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Political landscape
3.4.1.2. Economic and Social landscape
3.4.1.3. Technological landscape
3.4.1.4. Environmental landscape
3.4.1.5. Legal landscape
3.4.2. PESTEL Analysis
3.4.2.1. Bargaining power of the suppliers
3.4.2.2. Bargaining power of the buyers
3.4.2.3. Threats of substitution
3.4.2.4. Threats from new entrants
3.4.2.5. Competitive rivalry
CHAPTER 4. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: TRANSPLANT TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Artificial Corneal Implants Market: Transplant Type Analysis, 2024 & 2033 (USD Million)
4.3. Hard Keratoprosthesis
4.3.1. Hard Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2. Boston Kpro
4.3.2.1. Boston Kpro Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3. Osteo-Odonto-Keratoprosthesis
4.3.3.1. Osteo-Odonto-Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Soft Keratoprosthesis
4.4.1. Soft Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Artificial Corneal Implants Market: Indication Analysis, 2024 & 2033 (USD Million)
5.3. Stevens-Johnson syndrome (SJS)
5.3.1. Stevens-Johnson syndrome (SJS) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Ocular Cicatricial Pemphigoid (OCP)
5.4.1. Ocular Cicatricial Pemphigoid (OCP) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Ocular Burns
5.5.1. Ocular Burns Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Keratoconus
5.6.1. Keratoconus Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Corneal Stromal Dystrophies
5.7.1. Corneal Stromal Dystrophies Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: IMPLANT TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Artificial Corneal Implants Market: Implant Type Analysis, 2024 & 2033 (USD Million)
6.3. Synthetic
6.3.1. Synthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Biosynthetic
6.4.1. Biosynthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CorneaGen
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. AJL Ophthalmic S.A.
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Alcon inc.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. KeraMed, Inc.
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. FCI
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.4. Information Procurement
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Artificial Corneal Implants Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Political landscape
3.4.1.2. Economic and Social landscape
3.4.1.3. Technological landscape
3.4.1.4. Environmental landscape
3.4.1.5. Legal landscape
3.4.2. PESTEL Analysis
3.4.2.1. Bargaining power of the suppliers
3.4.2.2. Bargaining power of the buyers
3.4.2.3. Threats of substitution
3.4.2.4. Threats from new entrants
3.4.2.5. Competitive rivalry
CHAPTER 4. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: TRANSPLANT TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Artificial Corneal Implants Market: Transplant Type Analysis, 2024 & 2033 (USD Million)
4.3. Hard Keratoprosthesis
4.3.1. Hard Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2. Boston Kpro
4.3.2.1. Boston Kpro Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3. Osteo-Odonto-Keratoprosthesis
4.3.3.1. Osteo-Odonto-Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Soft Keratoprosthesis
4.4.1. Soft Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 5. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. U.S. Artificial Corneal Implants Market: Indication Analysis, 2024 & 2033 (USD Million)
5.3. Stevens-Johnson syndrome (SJS)
5.3.1. Stevens-Johnson syndrome (SJS) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Ocular Cicatricial Pemphigoid (OCP)
5.4.1. Ocular Cicatricial Pemphigoid (OCP) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Ocular Burns
5.5.1. Ocular Burns Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Keratoconus
5.6.1. Keratoconus Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Corneal Stromal Dystrophies
5.7.1. Corneal Stromal Dystrophies Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 6. U.S. ARTIFICIAL CORNEAL IMPLANTS MARKET: IMPLANT TYPE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. U.S. Artificial Corneal Implants Market: Implant Type Analysis, 2024 & 2033 (USD Million)
6.3. Synthetic
6.3.1. Synthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Biosynthetic
6.4.1. Biosynthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. CorneaGen
7.4.1.1. Company Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. AJL Ophthalmic S.A.
7.4.2.1. Company Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Alcon inc.
7.4.3.1. Company Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. KeraMed, Inc.
7.4.4.1. Company Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. FCI
7.4.5.1. Company Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. artificial corneal implants market 2021 - 2033 (USD Million)
Table 3 U.S. artificial corneal implants market: key market driver analysis
Table 4 U.S. artificial corneal implants market: key market restraint analysis
Table 5 U.S. artificial corneal implants market estimates and forecast, by transplant type (USD Million)
Table 6 U.S. artificial corneal implants market estimates and forecast, by indication (USD Million)
Table 7 U.S artificial corneal implants market estimates and forecast, by implant type (USD Million)
Table 8 U.S artificial corneal implants market estimates and forecast, by end use (USD Million)?
Table 1 List of abbreviations
Table 2 U.S. artificial corneal implants market 2021 - 2033 (USD Million)
Table 3 U.S. artificial corneal implants market: key market driver analysis
Table 4 U.S. artificial corneal implants market: key market restraint analysis
Table 5 U.S. artificial corneal implants market estimates and forecast, by transplant type (USD Million)
Table 6 U.S. artificial corneal implants market estimates and forecast, by indication (USD Million)
Table 7 U.S artificial corneal implants market estimates and forecast, by implant type (USD Million)
Table 8 U.S artificial corneal implants market estimates and forecast, by end use (USD Million)?
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. artificial corneal implants: market outlook
Fig. 10 U.S. artificial corneal implants competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. artificial corneal implants driver impact
Fig. 16 U.S. artificial corneal implants restraint impact
Fig. 17 U.S. artificial corneal implants strategic initiatives analysis
Fig. 18 U.S. artificial corneal implants: Transplant type movement analysis
Fig. 19 U.S. artificial corneal implants: Transplant type outlook and key takeaways
Fig. 20 Hard keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 21 Boston Kpro estimates and forecast, 2021 - 2033
Fig. 22 Osteo-odonto-keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 23 Soft keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 24 U.S. artificial corneal implants: Indication movement analysis
Fig. 25 U.S. artificial corneal implants: Indication outlook and key takeaways
Fig. 26 Stevens-Johnson syndrome (SJS) estimates and forecasts, 2021 - 2033
Fig. 27 Ocular cicatricial pemphigoid (OCP) estimates and forecasts, 2021 - 2033
Fig. 28 Ocular burn estimates and forecasts, 2021 - 2033
Fig. 29 Keratoconus estimates and forecasts, 2021 - 2033
Fig. 30 Corneal stromal dystrophies estimate and forecasts, 2021 - 2033
Fig. 31 OtherOthers estimates and forecasts, 2021 - 2033
Fig. 32 U.S. artificial corneal implants: Implant type movement analysis
Fig. 33 U.S. artificial corneal implants: Implant type outlook and key takeaways
Fig. 34 Synthetic estimates and forecasts, 2021 - 2033
Fig. 35 Biosynthetic estimates and forecasts, 2021 - 2033
Fig. 36 U.S. artificial corneal implants: End use movement analysis
Fig. 37 U.S. artificial corneal implants: End use outlook and key takeaways
Fig. 38 Hospitals estimates and forecasts, 2021 - 2033
Fig. 39 Ophthalmic center estimates and forecasts, 2021 - 2033
Fig. 40 Ambulatory surgical center estimates and forecasts, 2021 - 2033
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. artificial corneal implants: market outlook
Fig. 10 U.S. artificial corneal implants competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. artificial corneal implants driver impact
Fig. 16 U.S. artificial corneal implants restraint impact
Fig. 17 U.S. artificial corneal implants strategic initiatives analysis
Fig. 18 U.S. artificial corneal implants: Transplant type movement analysis
Fig. 19 U.S. artificial corneal implants: Transplant type outlook and key takeaways
Fig. 20 Hard keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 21 Boston Kpro estimates and forecast, 2021 - 2033
Fig. 22 Osteo-odonto-keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 23 Soft keratoprosthesis estimates and forecast, 2021 - 2033
Fig. 24 U.S. artificial corneal implants: Indication movement analysis
Fig. 25 U.S. artificial corneal implants: Indication outlook and key takeaways
Fig. 26 Stevens-Johnson syndrome (SJS) estimates and forecasts, 2021 - 2033
Fig. 27 Ocular cicatricial pemphigoid (OCP) estimates and forecasts, 2021 - 2033
Fig. 28 Ocular burn estimates and forecasts, 2021 - 2033
Fig. 29 Keratoconus estimates and forecasts, 2021 - 2033
Fig. 30 Corneal stromal dystrophies estimate and forecasts, 2021 - 2033
Fig. 31 OtherOthers estimates and forecasts, 2021 - 2033
Fig. 32 U.S. artificial corneal implants: Implant type movement analysis
Fig. 33 U.S. artificial corneal implants: Implant type outlook and key takeaways
Fig. 34 Synthetic estimates and forecasts, 2021 - 2033
Fig. 35 Biosynthetic estimates and forecasts, 2021 - 2033
Fig. 36 U.S. artificial corneal implants: End use movement analysis
Fig. 37 U.S. artificial corneal implants: End use outlook and key takeaways
Fig. 38 Hospitals estimates and forecasts, 2021 - 2033
Fig. 39 Ophthalmic center estimates and forecasts, 2021 - 2033
Fig. 40 Ambulatory surgical center estimates and forecasts, 2021 - 2033
